Clinical Trials
2
0 active
Approvals
0
Total approvals
Agencies
0
Regulatory bodies
Founded
N/A
No trial phase data available
Completed
1
50.0%
Terminated
1
50.0%
No approval data available
- A case-control pilot study used the S-PLEX electrochemiluminescence multiplex assay to quantify nine salivary cytokines in unstimulated whole saliva from 79 young adults. - Carious lesion samples showed significantly higher IL-17 and TNF-alpha levels than healthy controls and noncarious gingival inflammation samples. - The IL-17 plus TNF-alpha combination achieved the highest discriminatory accuracy for caries versus health, with an AUC of 0.901 (p<0.0001). - Researchers say the findings are hypothesis-generating and require validation in larger, more heterogeneous cohorts before clinical use.
• Bioanalytical techniques are driving precision medicine forward through three key areas: biomarker identification, therapeutic response monitoring, and development of targeted drugs for specific patient groups. • Advanced technologies like mass spectrometry, single-cell analysis, and CRISPR-based diagnostics are revolutionizing biomarker detection and validation, with HER2 testing in breast cancer demonstrating remarkable success. • Complex challenges in pharmacokinetic and pharmacodynamic studies, including individual patient variability and regulatory requirements, necessitate sophisticated bioanalytical approaches for successful precision medicine development.
